DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

MS Contin (Morphine) - Anaemia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Anaemia (15)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to MS Contin (Morphine) where reactions include anaemia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible MS Contin side effects in male

Reported by a physician from United States on 2012-06-29

Patient: male, weighing 67.1 kg (147.6 pounds)

Reactions: Atelectasis, Anaemia, Hypoxia, Sinus Tachycardia, Delirium, Thrombocytopenia

Drug(s) suspected as cause:
MS Contin
    Dosage: 2 mg, unk
    Administration route: Oral
    Indication: Pain
    Start date: 2012-04-01

Provenge
    Dosage: 250 ml,unk
    Indication: Prostate Cancer
    Start date: 2012-03-29
    End date: 2012-03-29

Dexamethasone Sodium Phosphate
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Multi-Vitamins; Digestive Enzymes; Leuprolide Acetate; Calcium Carbonate; Hydromorphone; Omeprazole; Vicodin



Possible MS Contin side effects in male

Reported by a pharmacist from United States on 2012-06-25

Patient: male, weighing 67.1 kg (147.6 pounds)

Reactions: Atelectasis, Anaemia, Hypoxia, Sinus Tachycardia, Delirium, Thrombocytopenia

Drug(s) suspected as cause:
MS Contin
    Dosage: 2 mg, unk
    Administration route: Oral
    Indication: Pain
    Start date: 2012-04-01

Provenge
    Indication: Prostate Cancer Metastatic

Dexamethasone
    Indication: Product Used FOR Unknown Indication

Provenge
    Dosage: 250 ml, unk
    Indication: Prostate Cancer
    Start date: 2012-03-29
    End date: 2012-03-29

Other drugs received by patient: Calcium Carbonate; Digestive Enzymes; Hydromorphone HCL; Leuprolide Acetate; Multivitamin / 00097801 /; Vicodin; Omeprazole



Possible MS Contin side effects in 66 year old male

Reported by a physician from United States on 2012-06-18

Patient: 66 year old male, weighing 67.0 kg (147.4 pounds)

Reactions: Atelectasis, Back Pain, Anaemia, Hyperglycaemia, General Physical Health Deterioration, Lymphangiosis Carcinomatosa, Delirium, Arthralgia, Thrombocytopenia, Metastases To Central Nervous System, Sinus Tachycardia, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
MS Contin
    Administration route: Oral
    Indication: Pain

Decadron
    Administration route: Oral

Provenge
    Indication: Prostate Cancer
    Start date: 2012-03-29
    End date: 2012-03-29

Other drugs received by patient: Calcium Carbonate; Digestive Enzymes; Vitamins (Unspecified); Vicodin; Omeprazole; Hydromorphone; Lupron



Possible MS Contin side effects in male

Reported by a physician from United States on 2012-06-15

Patient: male, weighing 67.1 kg (147.6 pounds)

Reactions: Atelectasis, Anaemia, Hypoxia, Sinus Tachycardia, Thrombocytopenia, Delirium

Drug(s) suspected as cause:
Digestive Enzymes
    Dosage: unk

Provenge
    Dosage: 250 ml, unk
    Indication: Prostate Cancer
    Start date: 2012-03-29
    End date: 2012-03-29

MS Contin
    Dosage: 2 mg, unk
    Administration route: Oral
    Indication: Pain

Dexamethasone Sodium Phosphate Ophthalmic Solution,0.1%
    Dosage: unk

Other drugs received by patient: Multi-Vitamins; Calcium Carbonate; Omeprazole; Leuprolide Acetate; Vicodin; Hydromorphone



Possible MS Contin side effects in male

Reported by a physician from United States on 2012-06-14

Patient: male, weighing 67.1 kg (147.6 pounds)

Reactions: Atelectasis, Anaemia, Hypoxia, Delirium, Sinus Tachycardia, Thrombocytopenia

Drug(s) suspected as cause:
MS Contin
    Dosage: 2 mg, unk
    Administration route: Oral
    Indication: Pain

Digestive Enzymes
    Dosage: unk

Provenge
    Dosage: 250 ml, unk
    Indication: Prostate Cancer
    Start date: 2012-03-29
    End date: 2012-03-29

Hydromorphone

Dexamethasone Sodium Phosphate
    Dosage: unk

Other drugs received by patient: Leuprolide Acetate; Calcium Carbonate; Vicodin; Multi-Vitamins; Omeprazole



Possible MS Contin side effects in male

Reported by a physician from United States on 2012-06-05

Patient: male, weighing 67.1 kg (147.6 pounds)

Reactions: Atelectasis, Anaemia, Hypoxia, Delirium, Thrombocytopenia, Sinus Tachycardia

Drug(s) suspected as cause:
Provenge
    Dosage: 250 ml, unk
    Indication: Prostate Cancer
    Start date: 2012-03-29
    End date: 2012-03-29

MS Contin
    Dosage: 2 mg, unk
    Administration route: Oral
    Indication: Pain

Dexamethasone
    Indication: Product Used FOR Unknown Indication

Provenge
    Indication: Prostate Cancer Metastatic

Digestive Enzymes

Other drugs received by patient: Multivitamin / 00097801 /; Calcium Carbonate; Leuprolide Acetate; Vicodin; Omeprazole



Possible MS Contin side effects in 66 year old male

Reported by a physician from United States on 2012-06-04

Patient: 66 year old male, weighing 67.0 kg (147.4 pounds)

Reactions: Back Pain, Atelectasis, Anaemia, Hyperglycaemia, General Physical Health Deterioration, Lymphangiosis Carcinomatosa, Delirium, Arthralgia, Thrombocytopenia, Asthenia, Metastases To Central Nervous System, Sinus Tachycardia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
MS Contin
    Administration route: Oral
    Indication: Pain

Decadron
    Administration route: Oral

Provenge
    Indication: Prostate Cancer
    Start date: 2012-03-29
    End date: 2012-03-29

Other drugs received by patient: Vitamins (Unspecified); Digestive Enzymes; Calcium Carbonate; Lupron; Vicodin; Omeprazole; Hydromorphone



Possible MS Contin side effects in 66 year old male

Reported by a physician from United States on 2012-05-16

Patient: 66 year old male, weighing 67.1 kg (147.6 pounds)

Reactions: Atelectasis, Abasia, Disorientation, Hypoxia, Thrombocytopenia, Back Pain, Anaemia, Hyperglycaemia, General Physical Health Deterioration, Muscular Weakness, Lymphangiosis Carcinomatosa, Delirium, Arthralgia, Sinus Tachycardia, Asthenia, Metastases To Central Nervous System

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Provenge
    Dosage: 250 ml, single, intravenous
    Indication: Prostate Cancer Metastatic
    Start date: 2012-03-29
    End date: 2012-03-29

MS Contin
    Dosage: 2 mg, prn, oral
    Administration route: Oral
    Indication: Inadequate Analgesia
    Start date: 2012-03-29
    End date: 2012-03-29

MS Contin
    Dosage: 2 mg, prn, oral
    Administration route: Oral
    Indication: Pain
    Start date: 2012-03-29
    End date: 2012-03-29

Other drugs received by patient: Lupron; Digestive Enzymes (Betaine Hydrochloride, Bromelains, Cellulase, Pancr; Multivitamin (Ascorbi Acid, Calcium Pantotyhenate, Ergocalciferol, NIC; Calcium Carbonate; Vicodin; Omeprazole



Possible MS Contin side effects in 40 year old male

Reported by a physician from Hungary on 2011-12-08

Patient: 40 year old male

Reactions: Weight Decreased, Jaundice, Anaemia, Hypotension, Coma, Neoplasm Progression, Disorientation, Hepatic Enzyme Increased, Convulsion, Therapeutic Response Decreased, Urinary Retention, Hallucination

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Morphine
    Indication: Cancer Pain

MS Contin
    Administration route: Oral

Fentanyl-100
    End date: 2010-10-01

MS Contin
    Administration route: Oral
    Indication: Cancer Pain

Fentanyl-100
    End date: 2010-04-01

Fentanyl-100

Fentanyl-100

Nsaid
    Indication: Pain

MS Contin
    Administration route: Oral

Amitriptyline HCL
    Indication: Pain

MS Contin
    Administration route: Oral

Hydromorphone HCL
    Indication: Cancer Pain
    Start date: 2010-04-01
    End date: 2010-06-01

Fentanyl-100
    Indication: Cancer Pain

Fentanyl-100
    Start date: 2010-06-01

Gemcitabine
    Indication: Chemotherapy

Cisplatin
    Indication: Chemotherapy



Possible MS Contin side effects in 40 year old male

Reported by a physician from Hungary on 2011-11-18

Patient: 40 year old male

Reactions: Jaundice, Weight Decreased, Hypotension, Anaemia, Neoplasm Progression, Coma, Disorientation, Hepatic Enzyme Increased, Convulsion, Therapeutic Response Decreased, Urinary Retention, Hallucination

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Hydromorphone HCL
    Indication: Cancer Pain
    Start date: 2010-04-01
    End date: 2010-06-01

Fentanyl-100

Gemcitabine
    Indication: Chemotherapy

Cisplatin
    Indication: Chemotherapy

Fentanyl-100
    Indication: Cancer Pain

Fentanyl-100
    End date: 2010-10-01

Morphine
    Indication: Cancer Pain

Amitriptyline HCL
    Indication: Pain

Nsaid
    Indication: Pain

MS Contin
    Administration route: Oral

MS Contin
    Administration route: Oral

Fentanyl-100

Fentanyl-100
    Start date: 2010-06-01

MS Contin
    Administration route: Oral

Fentanyl-100
    End date: 2010-04-01

MS Contin
    Administration route: Oral
    Indication: Cancer Pain



Possible MS Contin side effects in 40 year old male

Reported by a physician from Hungary on 2011-11-14

Patient: 40 year old male

Reactions: Weight Decreased, Jaundice, Hypotension, Anaemia, Neoplasm Progression, Coma, Disorientation, Convulsion, Hepatic Enzyme Increased, Therapeutic Response Decreased, Urinary Retention, Hallucination

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Indication: Chemotherapy

MS Contin
    Administration route: Oral

Fentanyl
    Start date: 2010-06-01

Gemcitabine
    Indication: Chemotherapy

Fentanyl
    End date: 2010-04-01

Fentanyl

Fentanyl

Morphine
    Indication: Cancer Pain

Fentanyl
    Indication: Cancer Pain

MS Contin
    Administration route: Oral

Hydromorphone HCL
    Indication: Cancer Pain
    Start date: 2010-04-01
    End date: 2010-06-01

Fentanyl
    End date: 2010-10-01

Amitriptyline HCL
    Indication: Pain

Nsaid
    Indication: Pain

MS Contin
    Administration route: Oral
    Indication: Cancer Pain

MS Contin
    Administration route: Oral



Possible MS Contin side effects in 40 year old male

Reported by a physician from Hungary on 2011-11-08

Patient: 40 year old male

Reactions: Weight Decreased, Jaundice, Anaemia, Hypotension, Coma, Neoplasm Progression, Disorientation, Convulsion, Hepatic Enzyme Increased, Therapeutic Response Decreased, Urinary Retention, Hallucination

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Fentanyl-100
    Start date: 2010-06-01

Fentanyl-100

Fentanyl-100
    End date: 2010-04-01

MS Contin
    Administration route: Oral

MS Contin
    Administration route: Oral
    Indication: Cancer Pain

Gemcitabine
    Indication: Chemotherapy

Fentanyl-100

Amitriptyline HCL
    Indication: Pain

Cisplatin
    Indication: Chemotherapy

Hydromorphone HCL
    Indication: Cancer Pain
    Start date: 2010-04-01
    End date: 2010-06-01

MS Contin
    Administration route: Oral

Nsaid
    Indication: Pain

MS Contin
    Administration route: Oral

Fentanyl-100
    Indication: Cancer Pain

Fentanyl-100
    End date: 2010-10-01

Morphine
    Indication: Cancer Pain



Possible MS Contin side effects in 40 year old male

Reported by a physician from Hungary on 2011-11-07

Patient: 40 year old male

Reactions: Weight Decreased, Jaundice, Hypotension, Anaemia, Neoplasm Progression, Coma, Disorientation, Hepatic Enzyme Increased, Convulsion, Therapeutic Response Decreased, Urinary Retention, Hallucination

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
MS Contin
    Administration route: Oral

MS Contin
    Administration route: Oral

Amitriptyline HCL
    Indication: Pain

Cisplatin
    Indication: Chemotherapy

Fentanyl

Fentanyl
    Indication: Cancer Pain

Fentanyl

Nsaid
    Indication: Pain

MS Contin
    Administration route: Oral
    Indication: Cancer Pain

Fentanyl
    End date: 2010-04-01

Fentanyl
    Start date: 2010-06-01

Hydromorphone HCL
    Indication: Cancer Pain
    Start date: 2010-04-01
    End date: 2010-06-01

Morphine
    Indication: Cancer Pain

MS Contin
    Administration route: Oral

Gemcitabine
    Indication: Chemotherapy

Fentanyl
    End date: 2010-10-01



Possible MS Contin side effects in 40 year old male

Reported by a physician from Hungary on 2011-10-19

Patient: 40 year old male

Reactions: Jaundice, Weight Decreased, Anaemia, Hypotension, Coma, Neoplasm Progression, Disorientation, Hepatic Enzyme Increased, Convulsion, Therapeutic Response Decreased, Urinary Retention, Hallucination

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Fentanyl

Cisplatin
    Indication: Chemotherapy

Amitriptyline HCL
    Indication: Pain

Morphine
    Indication: Cancer Pain

MS Contin
    Administration route: Oral

Hydromorphone HCL
    Indication: Cancer Pain
    Start date: 2010-04-01
    End date: 2010-06-01

Fentanyl
    Indication: Cancer Pain

Fentanyl
    End date: 2010-10-01

Fentanyl

Fentanyl
    End date: 2010-04-01

Fentanyl
    Start date: 2010-06-01

Nsaid
    Indication: Pain

MS Contin
    Administration route: Oral
    Indication: Cancer Pain

MS Contin
    Administration route: Oral

MS Contin
    Administration route: Oral

Gemcitabine Hydrochloride
    Indication: Chemotherapy



Possible MS Contin side effects in 39 year old male

Reported by a physician from United States on 2011-10-10

Patient: 39 year old male

Reactions: Weight Decreased, Confusional State, Bile Duct Obstruction, Drug Effect Decreased, Dysphagia, Anaemia, Hypotension, General Physical Health Deterioration, Neoplasm Progression, Somnolence, Malaise, Cholangitis, Urinary Retention, Hallucination, Muscle Spasms

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Exalgo
    Dosage: 32 mg, unk
    Indication: Cancer Pain
    Start date: 2010-04-01
    End date: 2010-06-01

Morphine
    Dosage: 20 mg, single
    Indication: Pain
    Start date: 2010-01-01
    End date: 2010-01-01

Fentanyl-100
    Dosage: 125 ug/hr, unk
    Start date: 2010-06-01
    End date: 2010-01-01

Fentanyl-100
    Dosage: 150 ug/hr, unk
    Start date: 2010-01-01

Fentanyl-100
    Dosage: 200 ug/hr, unk
    Start date: 2010-01-01
    End date: 2010-01-01

Gemcitabine Hydrochloride
    Dosage: 3 series of 8 treatments
    Indication: Chemotherapy
    Start date: 2010-04-01
    End date: 2010-07-01

Nsaid's
    Dosage: prn pain
    Indication: Pain

FEM Protocol
    Dosage: 2 series
    Start date: 2010-01-01

Fentanyl-100
    Dosage: 50 ug/hr, unk
    Indication: Cancer Pain

Fentanyl-100
    Dosage: unk
    Start date: 2010-01-01
    End date: 2010-01-01

Fentanyl-100
    Dosage: 100 ug/hr, unk
    Start date: 2010-01-01
    End date: 2010-01-01

Nsaid's
    Dosage: regularly administered

Cisplatin
    Dosage: 3 series of 8 treatments
    Indication: Chemotherapy
    Start date: 2010-04-01
    End date: 2010-07-01

MS Contin
    Dosage: 3 x130 mg
    Administration route: Oral
    Indication: Cancer Pain
    Start date: 2010-10-01

Fentanyl-100
    Dosage: 75 ug/hr, unk
    End date: 2010-04-01

Fentanyl-100
    Dosage: 250 ug/hr, unk
    Start date: 2010-01-01
    End date: 2010-10-01

MS Contin
    Dosage: 3 x 190 mg
    Administration route: Oral
    End date: 2010-01-01

MS Contin
    Dosage: 2 x 90 mg
    Administration route: Oral
    Start date: 2010-01-01

Morphine Sulfate
    Dosage: unk
    Indication: Breakthrough Pain
    Start date: 2010-01-01

Amitriptyline HCL
    Dosage: 2 x 1
    Indication: Pain

Other drugs received by patient: Proton Pump Inhibitors

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017